Not available
Quote | Cidara Therapeutics Inc. (NASDAQ:CDTX)
Last: | $12.51 |
---|---|
Change Percent: | 7.33% |
Open: | $11.75 |
Close: | $12.51 |
High: | $13.1999 |
Low: | $11.75 |
Volume: | 53,967 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
News | Cidara Therapeutics Inc. (NASDAQ:CDTX)
NEW YORK, NY / ACCESSWIRE / May 2, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cidara Therapeutics, Inc. ("Cidara" or "the Company") (NASDAQ:CDTX). Investors who purchased Cidara securities are encouraged to obtain additional informa...
2024-04-26 18:01:25 ET Summary Cidara Therapeutics, Inc. passed rezafungin rights to Mundipharma allowing reallocation of resources to the oncology Cloudbreak platform. Following a considerable private placement and re-acquisition of CD388 from Janssen, CDTX is well funded to star...
Message Board Posts | Cidara Therapeutics Inc. (NASDAQ:CDTX)
Subject | By | Source | When |
---|---|---|---|
$CDTX Should be up bigly tomorrow. Pres and | MiamiGent | investorshub | 03/28/2023 12:32:15 AM |
$CDTX Just added @ .95 | MiamiGent | investorshub | 03/27/2023 4:27:23 PM |
Interesting announcement by 5AM Ventures..... they | now invest | investorshub | 03/23/2023 2:52:53 PM |
Hello Ed. Also check out $ADRX. That one | enthalpy | investorshub | 03/23/2023 12:47:37 PM |
still losing money but is is narrowing | ed3/6me | investorshub | 03/23/2023 12:00:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Cidara Therapeutics Inc. Company Name:
CDTX Stock Symbol:
NASDAQ Market:
Cidara Therapeutics Inc. Website:
NEW YORK, NY / ACCESSWIRE / May 2, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cidara Therapeutics, Inc. ("Cidara" or "the Company") (NASDAQ:CDTX). Investors who purchased Cidara securities are encouraged to obtain additional informa...
SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak&...
SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serio...